May 8, 2019
British 17-year-old Isabelle Holdaway is reported to be the first patient ever to receive a genetically modified phage therapy to treat a drug-resistant infection.
Commentary
Commentary
Source: Wikipedia (CC BY-SA)
On May 8, in the year 2019:
British 17-year-old Isabelle Holdaway is reported to be the first patient ever to receive a genetically modified phage therapy to treat a drug-resistant infection.
Phage therapy, viral phage therapy, or phagotherapy is the therapeutic use of bacteriophages for the treatment of pathogenic bacterial infections.
Commentary
Source: Internal
Why May 8, 2019 matters:
British 17-year-old Isabelle Holdaway is reported to be the first patient ever to receive a genetically modified phage therapy to treat a drug-resistant infection.
What began on this day left a lasting mark on history. The effects were felt immediately and continued to shape events, ideas, and lives long afterwards.
Commentary
Source: Internal
Historical context: May 8, 2019
The 21st century has already seen profound shifts: the digital revolution has connected billions while reshaping politics and culture; climate change has emerged as a defining crisis; and new powers have risen to challenge the world order that followed the Cold War.
The event on this day: British 17-year-old Isabelle Holdaway is reported to be the first patient ever to receive a genetically modified phage therapy to treat a drug-resistant infection.
Source: https://en.wikipedia.org/wiki/Phage_therapy (Wikipedia, CC BY-SA)
Commentary
Commentary
Commentary
Commentary